The DTC model aligns with Most-Favored-Nation pricing, aiming to close the US drug price gap with other high-income countries ...
In today’s Pharmaceutical Executive Daily, we cover the emergence of TrumpRx and its implications for direct-to-consumer drug ...
TrumpRx and a most-favored nation policy won’t lower prices for patients, writes the CEO and co-founder of I-MAK.
We need to find ways to lower prescription prices, and it seemed like President Donald Trump was working on a promising ...
Sen. Bernie Sanders (I-Vt.) just made a shocking admission in favor of President Donald Trump. In an interview on “The Tim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback